Product Categories
| Country: | United States |
|---|---|
| Tel: | +86-0714-3992388 |
| Mobile: | +86-15391658522 |
| E-mail: | overseasales@yongstandards.com |
| QQ: | 2853117752 |
| Skype: | Chat Now! |
| Address: | No.176,Hangzhou West Road, Xialu Area, Huangshi |
|
China National Standard Pharmaceutical Corporation Limited is a strict standard company. Its main members are former senior employees from EDQM and The United States Pharmacopeial Convention. Standardpharm Co., Ltd. work together with Standardpharm CHN Co., Ltd. to serve scientists in the field of generic pharmaceuticals and innovative pharmaceuticals worldwide.
Standardpharm Co., Ltd. is a professional company specializing in the custom synthesis of pharmaceutical reference standards for biomedical and pharmaceutical research. We supply reference standards worldwide to clients base that includes major biotechnology corporations, pharmaceutical and diagnostic companies, clinical and bio-analytical CROs, manufacturers of specialty chemicals, as well as hospital researchers, universities and various other research institutions, including EDQM, USP, BP, JP, CHP, and Pfizer, TEVA, etc.
Standardpharm has over 600,000 products in 10 application area, including: Pharmaceutical Impurities, Pesticide and Veterinary Pharmaceutical Residues, Isotopes, Essence and Pigment, Criminal Justice Medicine, Natural pharmaceutical Extraction, Cosmetic, Environmental Protection, Food safety, Industrial Auxiliary Materials. Certificate of Analysis (COA) will be provided for all these products which characterized using HPLC/GC, MS, HNMR, synthetic route, spectrum analysis and other testing (CNMR, FNMR, COSY, NOESY, DEPT, HMBC, HMQC, HSQC, IR, UV, QNMR, TGA, elemental analysis, etc. ) as requested spectra by our clients. And STD Promises to return or exchange the goods to solve the problem as quickly as possible if any quality problem is found within the contractual period. STD has inventory in both China and the United States to ensure the fastest delivery for customers.
Welcome to consult us by email in any time.
|
|
| Product Name | MF | CAS | Details |
|---|
| Entacapone Impurity 10 | C7H5NO6 | 84211-30-3 | Details |
| Entecavir Impurity 15 | C53H49N5O4 | 142217-80-9 | Details |
| Enzalutamide Impurity 14 | C8H7BrFNO | 749927-69-3 | Details |
| Enzalutamide Impurity 20 | C8H9FN2O | 915087-25-1 | Details |
| Entecavir Impurity 22 | C14H21N5O3Si | 870614-82-7 | Details |
| Epalrestat Impurity 17 | C13H18O | 109801-00-5 | Details |
| Entacapone Impurity 8 (Entacapone EP Impurity H) | C15H15N3O5 | 1150310-15-8 | Details |
| Entacapone Impurity 4（Entacapone EP Impurity D） | C16H19N3O5 | 857629-79-9 | Details |
| Entacapone Impurity 22 | C8H7NO5 | 6635-20-7 | Details |
| Emtricitabine Impurity 6 | C14H24O4S | 147126-64-5 | Details |
| Enzalutamide Impurity 26 | C20H18F4N4O2 | 1289942-55-7 | Details |
| Entecavir Impurity 51 | C26H27N5O3 | 1354695-85-4 | Details |
| Epalrestat Impurity 21 | C12H9NO3S2 | 1431637-29-4 | Details |
| Entecavir Impurity 17（Entecavir EP Impurity C） | C12H15N5O4 | 2204369-23-1 | Details |
| Enzalutamide Impurity 11 | C21H18F4N4O3S | 2030242-21-6 | Details |
| Entacapone Impurity 15 | C8H7NO5 | 2454-72-0 | Details |
| Emtricitabine Impurity 8 | C8H10FN3O4 | 145397-26-8 | Details |
| Entecavir Impurity 16 | C26H27N5O3 | 142217-81-0 | Details |
| Epalrestat Impurity 36 | C10H10O2 | 1199-77-5 | Details |
| Entecavir Impurity 5（Entecavir EP Impurity D） | C12H15N5O3 | 1367369-80-9 | Details |
| Entecavir Impurity 1 | C12H15N5O3 | 1367369-76-3 | Details |
| Epalrestat Impurity 8 | C10H10O | 101-39-3 | Details |
| Enalapril Impurity 6(Enalapril EP Impurity G) | C15H27NO4 | 460720-14-3 | Details |
| Entecavir Impurity 50 | C26H27N5O3 | 1354695-86-5 | Details |
| Epalrestat Impurity 38 | C17H17NO3S2 | 682775-71-9 | Details |
| Entacapone Impurity 6 (Entacapone EP Impurity F) | C10H6N2O6 | 160391-70-8 | Details |
| Entacapone Impurity 13 | C15H17N3O5 | 158693-04-0 | Details |
| Enalapril Impurity 2（Enalapril EP Impurity A） | C20H28N2O5 | Details |
| Epalrestat Impurity 4（Epalrestat (E, Z)-Isomer） | C15H13NO3S2 | 124782-64-5 | Details |
| Epalrestat Impurity 29 Diammonium Salt | C3H8N2O2S2 | 6861-95-6 | Details |
| Enalapril Impurity 9 | C20H28N2O5 | 1177443-45-6 | Details |
| Entecavir Impurity 13 | C52H49N5O5 | 142217-78-5 | Details |
| Enrofloxacin Impurity 7（Enrofloxacin EP Impurity G） | C15H16FN3O3 | 103222-12-4 | Details |
| Epalrestat Impurity 6 | C16H15NOS2 | 332406-96-9 | Details |
| Enalapril Impurity 1(Enalapril EP Impurity D) | C20H26N2O4 | 115729-52-7 | Details |
| Entecavir Impurity 2 | C12H15N5O3 | 1367369-79-6 | Details |
| Entacapone Impurity 7 (Entacapone EP Impurity G) | C11H9N3O5 | 1364322-41-7 | Details |
| Enzalutamide Impurity 44 | C12H14FNO4 | 1802242-46-1 | Details |
| Entacapone Impurity 5（Entacapone EP Impurity E） | C6H4N2O6 | 7659-29-2 | Details |
| Enalapril Impurity 14 | C20H28N2O5 | 2378310-72-4 | Details |
| Epinastine Impurity 1 Hydrochloride（Epinastine EP Impurity A Hydrochloride） | C16H14ClN3 | 141342-70-3 | Details |
| Entacapone Impurity 23 | 4097-63-6 | Details |
| Enzalutamide Impurity 2 | C20H14F4N4O2S | 1242137-16-1 | Details |
| Enzalutamide Impurity 1 | C20H13F4N3O3S | 1242137-15-0 | Details |
| Entecavir Impurity 9（Entecavir EP Impurity E） | C13H17N5O4 | 2203740-23-0 | Details |
| Epalrestat Impurity 7 | C5H5NO3S2 | 5718-83-2 | Details |
| Epalrestat Impurity 5 | C14H11NO3S2 | 1800597-47-0 | Details |
| Entecavir Impurity 49 | C26H27N5O3 | 1354695-84-3 | Details |
| Entecavir Impurity 7（Entecavir EP Impurity B） | C12H15N5O3 | 1367369-77-4 | Details |
| Entecavir Impurity 37 | C26H27N5O3 | 1354695-82-1 | Details |
| Epalrestat Impurity 9 | C12H9NO3S2 | 1151944-57-8 | Details |
| Epalrestat Impurity 23 | C15H13NO4S | 794510-29-5 | Details |
| Enrofloxacin Impurity 3（Enrofloxacin EP Impurity C） | C19H23N3O3 | 138892-82-7 | Details |
| Emtricitabine Impurity 7 | C14H24O4S | 147027-08-5 | Details |
| Enzalutamide Impurity 12 | C17H8F6N4O | 1895865-11-8 | Details |
| Enalapril Impurity 13 | C20H28N2O5 | 649756-01-4 | Details |
| Enzalutamide Impurity 49 | C10H13NO2 | 177960-04-2 | Details |
| Entecavir Impurity 47 | C13H16O3 | 117641-39-1 | Details |
| Enzalutamide Impurity 15 | C8H6BrFO2 | 179232-29-2 | Details |
| Entecavir Impurity 19（Entecavir EP Impurity F） | C27H31N5O2Si | 649761-24-0 | Details |
| Entecavir Impurity 6（Entecavir EP Impurity A） | C12H15N5O3 | 1367369-78-5 | Details |
| Enzalutamide Impurity 5 | C21H17F3N4O2S | 915087-16-0 | Details |
| Enalapril Impurity 4(Enalapril EP Impurity E) | C26H32N2O5 | 2292151-89-2 | Details |
| Epalrestat Impurity 39 | C14H20O2 | 149217-17-4 | Details |
| Enzalutamide Impurity 13 | C7H4BrFO2 | 112704-79-7 | Details |
| Enoxolone Impurity 1 (Enoxolone EP Impurity A) | C30H46O4 | 1449-05-4 | Details |
| Entecavir Impurity 14 | C52H47N5O5 | 142217-79-6 | Details |
| Enrofloxacin Impurity 6（Enrofloxacin EP Impurity F） | C18H22FN3O | 131775-99-0 | Details |
| Ephedrine Impurity 5 (L-Phenylacetyl Carbinol) | C9H10O2 | 53439-91-1 | Details |
| Entacapone Impurity 11 | C15H17N3O5 | 857629-78-8 | Details |
| Entacapone Impurity 1（Entacapone EP Impurity A） | C14H15N3O5 | 145195-63-7 | Details |
| Entecavir Impurity 20 | C12H15N5O4 | 1984788-96-6 | Details |
| Epalrestat Impurity 29 | C3H5NO2S2 | 2041-59-0 | Details |
| Entacapone Impurity 9（Entacapone EP Impurity I） | C13H12N2O6 | 1364322-42-8 | Details |
| Entecavir Impurity 4 | C12H15N5O3 | 1333204-94-6 | Details |
| Epalrestat Impurity 10 | C10H10O | 66051-14-7 | Details |
| Entecavir Impurity 21 | C21H20O2 | 84868-56-4 | Details |
| Epalrestat Impurity 37 | C5H5NO3S2 | 179027-75-9 | Details |
| Entecavir Impurity 45 | C17H22ClN5O4 | 1354715-30-2 | Details |
| Enalapril Impurity 12 | C20H28N2O5 | 1217462-91-3 | Details |
| Moexipril Impurity 6 (Moexipril USP RC F) | C15H21NO4 | 82717-96-2 | Details |
| Entacapone Impurity 14 | C8H7NO5 | 2450-26-2 | Details |
| Epalrestat Impurity 29 Dipotassium Salt | C3H6KNO2S2 | 81885-12-3 | Details |
| Entecavir Impurity 48 | C20H22O3 | 110567-22-1 | Details |
| Epalrestat Impurity 32 | C12H9NO3S2 | 82159-06-6 | Details |
| Entecavir Impurity 23 | C13H16O2 | 110567-21-0 | Details |
| Epalrestat Impurity 28 | C5H5NO4S | 31061-24-2 | Details |
| Entecavir Impurity 3 | C12H15N5O3 | 188399-46-4 | Details |
| Epalrestat Impurity 22 | C7H9NO3S2 | 23176-01-4 | Details |
| Enzalutamide Impurity 33 | C12H15FN2O3 | 1289942-66-0 | Details |
| Enzalutamide Impurity 32 | C13H17FN2O3 | 1332524-01-2 | Details |
| Epalrestat Impurity 2（Epalrestat (Z, Z)-Isomer） | C15H13NO3S2 | 124782-63-4 | Details |
| Epalrestat Impurity 11 | C16H15NO3S2 | 682775-70-8 | Details |
| Enzalutamide Impurity 3 | C21H16F4N4O3 | 1242137-18-3 | Details |
| Enalapril Impurity 5 Monomer(Enalapril EP Impurity F Monomer) | C22H32N2O5 | 76391-34-9 | Details |
| Enalapril Impurity 7(Enalapril EP Impurity H) | C20H28N2O5 | Details |
| Enzalutamide Impurity 28 | C10H7F3N2OS | 1895865-10-7 | Details |
| Emtricitabine Impurity 5 | C14H24O4S | 147126-63-4 | Details |
| Epalrestat Impurity 3（Epalrestat (E, E)-Isomer） | C15H13NO3S2 | 863988-85-6 | Details |
| Enzalutamide Impurity 51 | C16H10F3N3OS | 1895865-08-3 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||